Apr 02,2015

t:slim® Insulin Pump Named #1 by Pump Users for Second Year in a Row

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that the t:slim Insulin Pump was again ranked first in overall satisfaction when compared to other commonly used insulin pumps in the United States. The study was conducted by independent market research company dQ&A and included data from a patient panel of 1,170 pump users. This is the second year in a row that the t:slim Pump has ranked first for overall satisfaction by dQ&A's Patient Panel.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Apr 03,2015

Artificial pancreas software algorithm receives approval in europe

The Glucositter software algorithm has received a CE Mark in Europe, but the big question is when and how this software will reach patients. Currently, the system runs on a laptop, but a handheld device for patients is an ideal choice. DreaMed Diabetes is the company in charge of commercializing the closed-loop system consisting of software algorithm, pump, and continuous glucose monitoring (CGM).

REGULATORY CE MARK

#closed loop

#cgm

View Analyst & Ambassador Comments
Go to original news
Apr 06,2015

BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2015 earnings conference call on Thursday, May 7, 2015, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.

View Analyst & Ambassador Comments
Go to original news
Apr 07,2015

Diabetics worldwide to benefit from artificial pancreas

Israeli medical tech firm DreaMed Diabetes has struck a deal with Medtronic, the world’s biggest medical device company, to use its MD-Logic Artificial Pancreas algorithm in Medtronic’s insulin pumps. Under the terms of the agreement, DreaMed Diabetes will receive undisclosed royalties from future sales of each device utilizing MD-Logic. In addition, Medtronic has made a minority investment in DreaMed Diabetes of $2 million.

COLLABORATION PARTNERSHIP

#product & service

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Apr 07,2015

Insulet Corporation to Announce First Quarter 2015 Financial Results on April 30, 2015

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced plans to release its financial results for the first quarter of 2015 on April 30, 2015 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Apr 15,2015

Tandem Diabetes Care Schedules First Quarter 2015 Earnings Press Release and Conference Call

Tandem Diabetes Care®, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, plans to release its first quarter 2015 results after the financial markets close on Thursday, April 30, 2015. The Company will hold a conference call and simultaneous webcast on the same day at 5:30pm Eastern Time (2:30pm Pacific Time), to discuss its first quarter 2015 financial and operating results.

View Analyst & Ambassador Comments
Go to original news
Apr 20,2015

Tandem Diabetes Care Now Shipping t:slim® Insulin Pump with Updated Software

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today commenced shipments of t:slim Pumps featuring enhanced software. The updated software, based on customer and healthcare provider feedback, includes an expansion of the reverse correction function, the ability to enter a manual bolus directly in the suggested bolus window, off-pump cartridge filling, and other features to enhance convenience and flexibility.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Apr 22,2015

BD "Dynamic Duos" Education Campaign Aims to Help People Simplify Life with Diabetes

Diabetes is a complex disease that can often be overwhelming, creating barriers that may prevent people with diabetes from enjoying the same opportunities as the rest of the population. To help address this issue, BD Medical, a segment of BD is raising awareness of the dynamic role of diabetes educators, whose knowledge and expertise can simplify life for people with diabetes.

View Analyst & Ambassador Comments
Go to original news
Apr 23,2015

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences: Deutsche Bank 40th Annual Health Care Conference, which will be held at the InterContinental Boston Hotel in Boston, Massachusetts on Wednesday, May 6, 2015 at 4:10pm Eastern Time (1:10pm Pacific Time), and Bank of America Merrill Lynch 2015 Health Care Conference, which will be held at the Encore at the Wynn Hotel in Las Vegas, Nevada on Wednesday, May 13, 2015 at 1:00pm Eastern Time (10:00am Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Apr 30,2015

Tandem Diabetes Care Reports First Quarter 2015 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today reported its financial results for the quarter ended March 31, 2015. For the first quarter of 2015, operating expenses totaled $23.2 million compared to $21.7 million for the same period of 2014, while Gross margin was 23 percent for the quarter ended March 31, 2015 compared to 11 percent in the same period of 2014. Sales grew 53 percent to $12.3 million from $8.1 million YoY.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES